Welcome to Medications.com

Levothyroxine Sodium News

FDA acts to ensure thyroid drugs don’t lose potency before ... - NEWSFOOD.com Primo piano

The US Food and Drug Administration is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other ...

Posted: Thu Oct 04 12:39:46 -0400 2007

US FDA Tightening Potency Standards For Thyroid Drugs - CNNMoney.com

The FDA is mandating manufacturers of levothyroxine sodium drugs to tighten their potency specifications to meet a 95% to 105% potency specification until ...

http://money.cnn.com/news/newsfee... | Posted: Wed Oct 03 12:46:37 -0400 2007

FDA to Monitor Thyroid Drug For Potency, Expiration Date - Associated Content

By Regina Sass Concerns have been expressed about a drug called levothyroxine sodium, which is used to treat underactive thyroid glands as well as other ...

http://www.associatedcontent.com/... | Posted: Thu Oct 04 14:13:45 -0400 2007

US FDA Tightening Potency Standards For Thyroid Drugs - CNNMoney.com

all 132 news articles

Posted: Wed Oct 03 12:46:37 -0400 2007

New Potency Requirement for Levothyroxine - Facts and Comparisons

The FDA is mandating that levothyroxine sodium drug products tighten their potency specifications to meet 95% to 105% potency specifications until their ...

http://factsandcomparisons.com/Ne... | Posted: Fri Oct 05 06:05:03 -0400 2007

FDA to Monitor Thyroid Drug For Potency, Expiration Date - Associated Content

By Regina Sass Concerns have been expressed about a drug called levothyroxine sodium, which is used to treat underactive thyroid glands as well as other ...

Posted: Thu Oct 04 14:13:45 -0400 2007

US FDA Tightening Potency Standards For Thyroid Drugs - CNNMoney.com

all 32 news articles

Posted: Wed Oct 03 12:46:37 -0400 2007

Patheon announces third quarter results - Canada NewsWire (press release)

Rx volumes declined in Caguas, Puerto Rico as a result of lower production of Zocor(R) and Levothyroxine sodium. This was offset in part by increased ...

http://www.newswire.ca/en/release... | Posted: Fri Sep 07 04:05:43 -0400 2007

Patheon announces third quarter results - Canada NewsWire (press release)

Rx volumes declined in Caguas, Puerto Rico as a result of lower production of Zocor(R) and Levothyroxine sodium. This was offset in part by increased ...

Posted: Fri Sep 07 04:05:43 -0400 2007

Jacobs Engineering Reveals Receipt Of Various Contracts - Quick ... - RTT News

In addition, the Alpharma would also receive exclusive US license and distribution rights to Tirosint, synthetic levothyroxine sodium gel capsules for ...

http://www.rttnews.com/sp/Quickfa... | Posted: Tue Aug 21 05:02:04 -0400 2007




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea